Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
The NATIONAL HEALTH INSURANCE FUND has issued a Tender notice for the procurement of a Itemized Accounted and other Active Ingredients in the Hungary. This Tender notice was published on 10 Apr 2025 and is scheduled to close on 12 May 2025, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 117490231, while the tender notice number is 232139-2025 and Registering on the platform.
Procurement Summary
Country: Hungary
Summary: Itemized Accounted and other Active Ingredients
Deadline: 12 May 2025
Posting Date: 10 Apr 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 117490231
Document Ref. No.: 232139-2025
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Purchase of the active ingredients of expired patent protection, as well as lapatinib and Durvvalumab active ingredients, is subject to the conclusion of the framework agreement, the Kbt. 105 (1) (a) of the Framework Agreement, further extensionwith the opportunity. The subject of this procurement procedure (in part): Part 1: Rituximab IV. (Oeno: 06058): Total amount: 24 000 000 mg (basic amount: 18, 000 000 mg + 6 000 000 mg option) Part 2: Ustkinumab (Oeno: 06056): Total frame quantity: 2 948 400 mg (basic amount: 2 211 300 mg +737 100 mg option) Part 3: Lapatinib (Oeno: 06061): Total frame quantity: 9, 030 000 mg (basic amount: 6, 020 000 mg + 3 010 000 mg option) Part 4: Durvalumab (Oeno: 06048): Total frame quantity: 8 550 000 mg MG Option) affected patient circle: The active ingredient ustkinumabIn the indications specified in the technical description, all patients are treated in the other active ingredients. The Kbt. In view of Article 73 (6) (c), the Contracting Authority draws the attention of the tenderers to all parts that the tender is invalid to be invalidThe offer, which contains a higher bid than: - for part 1 (rituximab): The last publicly available framework agreement (https://kekeo.kore.kore.kozjerzs.hu/megteses/202713/) for the rituximab active ingrediente...
Document Type: Contract Notice
Reference Number: Ekr000300212025
Contract Type: Supplies
ETHORITY TYPE: Body-Pl-Cga
Doc Title: Itemed Extemmitted and Other active ingredients
Dispatch Date: 2025-04-08
2025-04-10
Submission Date: 2025-05-12
Documents
Similar Tenders
Hungary
136935855
16 Mar 2026
Refer Document
Procurement Documents for Hungary
Access a comprehensive library of standard procurement documents specific to Hungary. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in Hungary
Want To Bid in This Tender?
Get Local Agent Support in Hungary and 60 More Countries.
View Tenders By
Sign in with Google